Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-08-25

Clinical Trial Update: The Treatment of Hypertension Associated With Severe Preeclampsia (PE). A Trial of Urapidil Versus Nicardipine [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing urapidil versus nicardipine for hypertension associated with severe preeclampsia was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nicardipine (nicardipine)
  • Urapidil (urapidil)

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Hypertension, Preeclampsia | Phase 3 | Status: TERMINATED